KALA BIO, Inc.
Market Cap
$772.31K
P/E Ratio
—
EPS
—
Dividend Yield
0.00%
52-Week Range
$0.10 — $19.48
Volume
41.99K
Avg Volume
320
Beta
-1.99
Get alerted when 0JQ2.L hits your target price.
Free — enter your email to get started
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.00
P/S (TTM)
15.80
P/B (TTM)
-0.15
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-23.24%
ROA (TTM)
-1.43%
ROIC
—
Gross Margin
-0.03%
Operating Margin
-150.56%
Net Margin
—
Debt/Equity
-3.58
Current Ratio
0.75
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.58%
EPS Growth (5Y)
+0.39%
Sales Growth (3Y)
-0.55%
Sales Growth (5Y)
-0.17%
EPS Est (This Year)
$-0.53
EPS Est (Next Year)
$-0.40
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$3.00
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
7.02M
Float
6.78M
Free Float %
96.59%
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
US
Exchange
LSE
IPO Date
2018-01-29
Employees
38
CEO
Avi Minkowitz
Index Membership
—
Website
https://www.kalarx.com
KALA BIO, Inc. (0JQ2.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $772.31K, 0JQ2.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0JQ2.L against other stocks using dozens of fundamental and technical filters.
AZNH
AstraZeneca PLC ADRhedged
$53.74
+0.03%
$1.60M
BGMS
Bio Green Med Solution, Inc.
$0.98
+0.66%
$2.14M
NVOH
Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
$24.02
+3.63%
$2.15M
BGMSP
Bio Green Med Solution, Inc.
$1.10
+0.00%
$2.40M
0JGL.L
PCI Biotech Holding ASA
$0.07
-28.00%
$2.69M
IBO.V
Universal Ibogaine Inc.
$0.01
-50.00%
$1.56M
No, KALA BIO, Inc. (0JQ2.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
KALA BIO, Inc. (0JQ2.L) has a market capitalization of $772,314, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.